OPUS GENETICS INC (IRD:NASDAQ)
$3.69 -0.16 (-4.1558%)
Analysed OPUS GENETICS INC (IRD:NASDAQ) News Sources
Opus Genetics Announces Financial Results for First Quarter 2026 and Provides Corporate Update
12-05-2026
yahoo.com
Opus Genetics, Inc. (IRD) Reports Q1 Loss, Misses Revenue Estimates
12-05-2026
yahoo.com
Opus Genetics to Present at the RBC Capital Markets 2026 Global Healthcare Conference
13-05-2026
yahoo.com
Opus Genetics Touts Retinal Gene Therapy Pipeline, September BEST1 Data Catalyst
26-05-2026
marketbeat.com
Opus Genetics to Present at the 2026 Jefferies Global Healthcare Conference
27-05-2026
yahoo.com
Guggenheim Initiates Coverage Of Opus Genetics (IRD) With “Buy” Rating And $16 Price Target
10-06-2026
yahoo.com
Opus Genetics Added to the Russell 3000®, Russell 2000® and Russell Microcap® Indexes
26-06-2026
yahoo.com
Opus Genetics Provides BEST1 Program Update with Detailed Timeline for OPGx-BEST1 Results
09-07-2026
yahoo.com
Opus Genetics Announces Financial Results for Second Quarter 2026 and Provides Corporate Update
06-08-2026
yahoo.com
Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19-08-2026
yahoo.com
What is the current price of OPUS GENETICS INC (IRD:NASDAQ)?
The current price of OPUS GENETICS INC (IRD:NASDAQ) is $3.69.
OPUS GENETICS INC (IRD:NASDAQ) absolute price change since previous trading day?
The absolute price change of OPUS GENETICS INC (IRD:NASDAQ) since the previous trading day is $-0.16.
OPUS GENETICS INC (IRD:NASDAQ) percentage price change since previous trading day?
The percentage price change of OPUS GENETICS INC (IRD:NASDAQ) since the previous trading day is -4.1558%.
What is the most recent average sentiment score for OPUS GENETICS INC (IRD:NASDAQ)?
The most recent average sentiment score for OPUS GENETICS INC (IRD:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for OPUS GENETICS INC (IRD:NASDAQ)?
The most recent sentiment for OPUS GENETICS INC (IRD:NASDAQ) is .
SEC-8K** Filing Available For OPUS GENETICS INC (IRD:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.